Platform
Vaccine Innovation & Manufacturing
End-to-end vaccine research, clinical translation, and scalable manufacturing for rapid national response
Next generation bioscience platform
Saudi Arabia’s national biotechnology platform for Leadership, Health Security & Global Commercialization...
BioTUWAIQ enables Vision 2030 through technology transfer, advanced biomanufacturing, and world-class partnerships, delivering investment-grade biotechnology localization, sovereign health security, and globally competitive clinical and commercial outcomes.
Vision 2030 mandate
National Biotechnology Strategy execution & measurable impact
Investor-grade scale
Advanced manufacturing, technology transfer & IP localization
Health security
National preparedness with resilient biotech supply chains
Platform pillars
Technology transfer - Localization - Scale manufacturing
About BioTUWAIQ
Saudi Arabia’s Sovereign biotechnology platform
BioTUWAIQ is a Saudi biotechnology platform advancing technology transfer, advanced manufacturing & biotech commercialization across priority health domains. We build sovereign capability and globally competitive platforms aligned with Vision 2030 & the National Biotechnology Strategy to strengthen health security, scientific excellence & economic diversification
We establish national biotechnology capacity with international standards, strategic resilience, and long-term value creation
Strategic Pillar
Biotechnology Localization
Institutionalize global platforms in Saudi Arabia with integrated regulatory, clinical & manufacturing execution
Strategic Pillar
Health Security & Biosecurity
Advance national preparedness, resilient supply chains, and biosecurity capabilities critical to public health sovereignty
Strategic Pillar
Scientific Excellence
Build world-class research, translational science, and talent pipelines through global partnerships and applied R&D
Strategic Pillar
Biotech Commercialization
Scale sovereign biotech assets through advanced manufacturing, investment readiness & sustainable national returns
Platform Strategy
Vision 2030
Strategic Focus Areas
Saudi biotechnology focus areas for national health security and global competitiveness
BioTUWAIQ advances a disciplined Saudi biotechnology portfolio spanning vaccines, advanced therapeutics, and platform technologies to accelerate technology transfer, manufacturing readiness & international partnerships
Therapeutics
Cell & Gene Therapy
Localized cell and gene therapy pipelines with GMP readiness and global commercialization pathways
Oncology
Cancer Immunotherapy
Immune-oncology platforms and clinical partnerships targeting durable outcomes for complex cancers
Precision
Personalized Medicine & Genomics
Precision therapeutics informed by population genomics and real-world data for Saudi healthcare
Security
Biosecurity & Pandemic Preparedness
National biosecurity programs for surveillance, rapid response, and resilient public health systems
Defense
Counter‑Bioterrorism Technologies
Diagnostics, countermeasures, and response capabilities safeguarding national health security
Health
Drug Abuse Biotechnology Solutions
Biotech-enabled prevention, treatment, and monitoring programs supporting population health
Platforms
Advanced Viral Vector Platforms
Scalable viral vector design, GMP manufacturing, and quality systems for advanced therapeutics
Platform Strategy
Biotechnology platform strategy for commercialization in Saudi Arabia
BioTUWAIQ delivers a biotechnology platform strategy that unifies technology acquisition, technology localization, research, clinical development, biomanufacturing, and commercialization in Saudi Arabia. This integrated operating model drives scientific rigor, national alignment & investor-grade execution across the full biotech value chain
Directive Focus
- End-to-end biotechnology platform strategy from technology acquisition to commercialization.
- Modular, scalable pillars that localize critical biotech capabilities in Saudi Arabia.
- Governance and performance aligned with Vision 2030 and national biotechnology priorities.
Technology Acquisition
Strategic technology acquisition of high-impact biotech platforms and assets aligned with Saudi Arabia’s national priorities
Technology Localization
Structured technology localization to secure sovereign control of critical biotechnology value chains in Saudi Arabia
Intellectual Property
Intellectual property strategy, protection & portfolio expansion to strengthen global biotech competitiveness
Scientific Research
Translational scientific research programs built to accelerate discovery and deliver nationally relevant biotechnology
Clinical Development
Clinical development and regulatory alignment to de-risk innovation and advance high-value biotech programs
Biomanufacturing
Advanced biomanufacturing infrastructure for secure, scalable & compliant biotech production
Global Partnerships
Global biotech partnerships with innovators, universities, and strategic institutions to accelerate capability transfer
Commercialization
Commercialization, market access, and value capture to position Saudi biotechnology on the global stage
Executive Leadership
Institutional biotechnology leadership advancing commercialization, regulatory alignment, and Saudi Arabia’s global health security mandate
BioTUWAIQ’s executive leadership brings internationally credible biotechnology expertise, governance discipline, and partnership experience to scale Saudi biotech innovation, clinical development & strategic alliances across government and global industry
Leadership Mandate
Establish a globally competitive Saudi biotechnology institution delivering commercialization, regulatory readiness, technology transfer & long-term national impact aligned with Vision 2030
Founder & CEO
Dr. Ibrahim Alfayyadh
Biotechnology Platform Strategist
Biotechnology executive and entrepreneur directing BioTUWAIQ’s platform strategy, global partnerships, and investment alignment to advance scientific excellence, commercialization pathways & national biotechnology leadership for Saudi Arabia.
Co-Founder
Dr. Abdalraheem Alshobaki
Clinical Development, Regulatory Affairs & Government Engagement
Consultant physician and clinical development leader guiding regulatory alignment, government relations, and institutional governance to accelerate BioTUWAIQ’s clinical programs, compliance readiness & health security partnerships.
Strategic Impact
Strategic outcomes that position Saudi Arabia as a global biotechnology leader
BioTUWAIQ advances national biotechnology leadership through measurable economic diversification, technology transfer, research excellence & health security outcomes aligned with Vision 2030
Economic
Accelerating diversified growth
- Knowledge economy expansion
- Advanced biomanufacturing capacity
- Foreign direct investment attraction
- High-value biotechnology employment
Scientific
Advancing research excellence
- Strategic technology transfer
- World-class research excellence
- International scientific collaboration
- National biotechnology talent development
National
Securing strategic resilience
- Health security readiness
- Biotechnology sovereignty
- Pandemic preparedness capabilities
- National innovation leadership
Policy Alignment
Saudi Vision 2030 aligned biotechnology strategy for national transformation
BioTUWAIQ operates as a national biotechnology platform that converts Saudi Vision 2030 priorities into investable programs, aligning policy, translational science, and advanced manufacturing to scale biotechnology innovation in Saudi Arabia
Executive Narrative
Our alignment framework advances health sector transformation, biotechnology localization, and technology transfer as sovereign pillars of national competitiveness, delivering measurable outcomes for government, investors & global partners
01
Saudi Vision 2030
Positioning biotechnology as a driver of economic diversification, health security, and sovereign innovation with accountable national impact
02
National Biotechnology Strategy
Executing national biotechnology strategy priorities across advanced therapies, platform manufacturing, and technology transfer into investable pipelines
03
Health Sector Transformation Program
Advancing health sector transformation through localized production of critical biologics, vaccines, and pandemic-ready platform technologies
04
Research, Development & Innovation Strategy
Accelerating translational science through research partnerships, IP creation, and commercialization pathways that scale biotechnology innovation
05
Industrial Localization
Building biotechnology localization through advanced manufacturing of biologics, viral vectors, and next-generation modalities with global-quality standards
Strategic Collaboration
Sovereign biotechnology partnerships powering technology transfer, health security, and long-term industrial value
BioTUWAIQ aligns government decision-makers, global biotech leaders, and strategic capital to build Saudi Arabia’s sovereign biotechnology capability. We co-develop platforms, scale advanced biomanufacturing, and accelerate clinical development to deliver national transformation, resilient health security & globally competitive commercialization
Executive alignment
We invite long-horizon collaborations that combine sovereign capability building, strategic investment, and world-class science across technology acquisition, translational research, manufacturing scale-up & global market access
Invited collaboration groups
Institutional partners advancing sovereign capability, technology transfer & global commercialization
2030
Collaboration priorities
Technology transfer, co-development and licensing, advanced biomanufacturing, clinical development & global commercialization
Investor alignment
Strategic capital for Saudi Arabia’s biotechnology commercialization engine
BioTUWAIQ partners with sovereign funds, family offices, and long-term investors to scale advanced manufacturing, technology transfer, and national capability building. Together we deliver Vision 2030 outcomes through global biotech partnerships, localized IP & resilient health security infrastructure.
Commercialization at scale
Institutional pathways from asset acquisition to global launch
Advanced biomanufacturing
Localized production capacity aligned with national resilience
Strategic capital alignment
Long-horizon returns tied to Vision 2030 biotech outcomes
Executive investment engagement
Partner with a national biotechnology platform built for sovereign scale
We welcome strategic investment dialogues focused on technology localization, global commercialization & resilient healthcare infrastructure in the Kingdom
Confidential engagement for qualified institutional investors
Government & National Partnerships
Trusted institutional partner for national biotechnology advancement
BioTUWAIQ collaborates with ministries, regulators, public health authorities, and sovereign initiatives to strengthen health security, accelerate biotechnology localization, and deliver Vision 2030-aligned industrial capability with rigorous regulatory coordination
National Programs
Sovereign initiatives & transformation agendas
Co-design initiatives with national transformation programs, sovereign funds & strategic agencies to scale biotech platforms across priority sectors
Health Security Infrastructure
Pandemic readiness & biosecurity
Strengthen national preparedness through advanced surveillance, vaccine platforms, and secure biomanufacturing capacity
Regulatory & Policy Alignment
Evidence-led governance
Partner on regulatory harmonization, clinical governance & policy frameworks that enable safe, rapid biotech adoption
Industrial Localization
Technology transfer & local capability
Deliver sovereign manufacturing capability with integrated technology transfer, workforce development & commercialization pathways